U.S. markets closed

Roadman Investments Corp. (RMANF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.02300.0000 (0.00%)
At close: 9:30AM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0230
Open0.0230
BidN/A x N/A
AskN/A x N/A
Day's Range0.0230 - 0.0230
52 Week Range0.0004 - 0.1200
Volume300
Avg. Volume6,484
Market Cap2.8M
Beta (5Y Monthly)1.79
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • GlobeNewswire

    ROADMAN INVESTMENTS ENTERS INTO LETTER OF INTENT TO ACQUIRE PANASIA DISTRIBUTION CORP.

    Roadman and PanAsia will collaborate to integrate the Company’s recently acquired portfolio company CLOV Biopharma Corp’s (CBP) utilization of cedar leaf oil vapour in a variety of both clinical laboratory and real world commercial scenarios into the Asia Pacific region.

  • GlobeNewswire

    Roadman Investments Enters Into Definitive Agreement for Acquisition of CLOV Biopharma Corp.

    CLOV Biopharma Corp. is focused on conducting further research and development of cedar leaf oil vapour (“CLOV”) for the purposes of preventing the spread of Coronavirus and other similar potentially pathogenic respiratory viruses, for example, influenza and para-influenza viruses, and respiratory syncytial viruses. CBP is working in partnership with Dr. James Hudson, Ph.D, who is widely considered to be one of the foremost virologists in Canada, in an effort to expand upon and potentially commercialize his many years of study and scientific analysis involving the antimicrobial and antiviral properties of cedar leaf (Thuja plicata) oil.